Skip to main content
3D Medicines Inc. logo

3D Medicines Inc. — Investor Relations & Filings

Ticker · 1244 ISIN · KYG8872R1011 HKEX Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2024-08-20 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1244

About 3D Medicines Inc.

https://www.3d-medicines.com

3D Medicines Inc. is an oncology-focused, commercial-stage biopharmaceutical company specializing in the development and commercialization of next-generation immuno-oncology therapies. The company leverages global research and development capabilities and internal discovery platforms to advance a pipeline of innovative drug candidates. Its core mission is to address unmet medical needs in cancer treatment, aiming to transform cancer into a chronic disease and provide substantial value to patients and healthcare providers globally.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the Board of Directors of 3D Medicines Inc. stating the date of a board meeting to approve unaudited interim results for the six months ended June 30, 2024, and to consider the payment of an interim dividend. The document does not contain any financial data or the actual interim report; it only announces the upcoming board meeting and the intention to approve interim results. The document length is short (1415 characters) and it is clearly an announcement rather than the report itself. According to the rules, such announcements about the timing of report approval or board meetings are classified as Regulatory Filings (RNS) because it does not contain the actual interim report or financial statements.
2024-08-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report for movements in securities, specifically focusing on authorized and issued shares, share options, and confirmations related to compliance with listing rules on The Stock Exchange of Hong Kong Limited. It includes data on share capital, issued shares, share options, and confirmations by a director. The document is titled as a monthly return and is submitted to the Hong Kong Exchanges and Clearing Limited. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. It is a regulatory compliance filing related to share capital movements and confirmations under listing rules. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-08-05 English
ADOPTION OF CHINESE NAME AND CHANGE OF STOCK SHORT NAME
Regulatory Filings Classification · 95% confidence The document is an announcement from 3D Medicines Inc. regarding the adoption of a Chinese name and change of stock short name. It includes details about the approval at the annual general meeting, issuance of certificates, and effective dates for the name change. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management discussion. The document is a formal announcement about corporate identity and stock name changes, which does not fit into financial reports or earnings releases. It is not a regulatory filing in the sense of compliance or officer certification, but rather a general corporate announcement. Given the content and length (3822 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2024-07-30 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 June 2024. It details movements in authorised share capital, issued shares, share options, and confirms compliance with listing rules. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, focusing on share capital and share movements rather than financial performance or management commentary. The document is about share capital movements and confirmations related to securities issued or treasury shares, which aligns with announcements regarding share issues or capital changes. It is not a full financial report, earnings release, or management discussion. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length (8497 characters) and content confirm it is a substantive report on share capital movements, not merely an announcement of a report or a certification.
2024-07-05 English
Amended and Restated Memorandum and Articles of Association
Governance Information Classification · 100% confidence The document is titled 'Amended and Restated Memorandum of Association' and 'Amended and Restated Articles of Association' of 3D Medicines Inc., adopted pursuant to a special resolution passed on June 28, 2024. It contains detailed provisions about the company's name, registered office, objects, share capital, and extensive articles governing the company's internal rules, board structure, share rights, meetings, voting, directors, and other governance matters. There is no financial data, earnings information, or audit results. The document is a formal governance charter amendment rather than a financial report or announcement. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a mere announcement or summary.
2024-07-03 English
Amended and Restated Memorandum and Articles of Association
Governance Information Classification · 100% confidence The document is titled 'Amended and Restated Memorandum of Association' and 'Amended and Restated Articles of Association' of 3D Medicines Inc., adopted pursuant to a special resolution. It contains detailed company constitutional documents including company objects, share capital, board powers, shareholder rights, and procedural rules. It references the Companies Act (Cayman Islands) and the listing on The Stock Exchange of Hong Kong Limited. The content is legal and governance related, focusing on the internal rules and structure of the company rather than financial results, management commentary, or shareholder meeting materials. It is not an announcement or a brief notice but a full set of governing documents. Therefore, the appropriate classification is Governance Information (CGR).
2024-06-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.